Chen, L., Gao, N., Yang, W., Zhang, Q., Zhu, H., Zhang, Z., Liu, L., Wu, Y., Yao, J., Liu, Z., Hong, Z., Song, Y., Zhu, X., Miao, J., Yang, J., Tan, K., Liang, A. R., Xu, Z., Niu, T., Xiao, Z. (2025). Preliminary analysis of a phase 2b, randomized, active-control study of flonoltinib maleate (FM) vs. ruxolitinib in intermediate-2 or high-risk myelofibrosis patients. Blood. https://doi.org/10.1182/blood-2025-908